Kirkland Ultra Stregth Antacid 171ab Tablet
FDA Recall NDC 63981-171
FDA Enforcement Report: View Recall Date, Reasons, and Safety Status
Active & Historical Enforcement Reports
The FDA has identified 1 recorded enforcement report(s) associated with Kirkland Ultra Stregth Antacid 171ab (NDC 63981-171). A significant event, classified as Class II, was initiated on May 28, 2026 by Costco Wholesale Company. The reported reason for this action was: "Presence of foreign substance: small metallic particles in chewable tablets."
This recall is currently ONGOING. Healthcare providers and patients are advised to check their inventory immediately against the affected codes provided below.
This recall is currently ONGOING. Healthcare providers and patients are advised to check their inventory immediately against the affected codes provided below.
Reported Recall Events
Class II Ongoing
Presence of foreign substance: small metallic particles in chewable tablets.
May 28, 2026
Jun 10, 2026
N/A
Recall Profile & Regulatory Data
Event ID
99098
Classification
Class II
Enforcement Status
Ongoing
Recalling Firm
Guardian Drug Co. Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
U.S.A. Nationwide
Product Description
KIRKLAND Signature, ULTRA STRENGTH ANTACID, Calcium Carbonate, 1000 mg, 265-count bottle, MANUFACTURED BY: GUARDIAN DRUG COMPANY, INC., 2 CHARLES COURT/DAYTON, NJ 08810, FOR: Costco Wholesale Corporation, 999 Lake Drive, Issaquah, WA 98027, NDC 63981-171-80
Batch or Lot Expiration Information
Lot# : 1716059, 1716060, 1716061, 1716062, 1716063, 1716218, 1716219, 1716228, 1716229, 1716238, Exp 2/28/2029; 1716258, Exp 3/31/2029.
Affected Packages Involved in this Recall
63981-171-80Product
About FDA Recall Enforcement Reports
FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.
If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.
